β-lactamases are fundamental mediators of bacterial resistance to β-lactam antibiotics. Historically they are taught as a canonical example of cooperative resistance because their enzymatic activity can lower antibiotic concentrations in the local environment, thereby protecting nearby cells as well as the producing cell. However, recent synthesis highlights that the degree to which β-lactamase activity is truly social—i.e., shared among cells—varies substantially depending on mechanistic and ecological context. Rather than a binary classification, β-lactamase action should be considered along a spectrum from largely private benefits to broadly cooperative effects.
The physical and molecular localisation of β-lactamases strongly influences whether the enzyme’s detoxifying effect is confined to the producing cell or extends to neighbours. When enzyme activity is restricted intracellularly or tightly associated with the periplasm, the protective benefit is more likely to be private. By contrast, enzymes that are released or active outside the immediate producing cell can reduce extracellular antibiotic concentrations and thereby confer protection to non-producer cells.
Two mechanistic features emphasised in recent work are membrane anchoring and packaging into outer-membrane vesicles (OMVs). Membrane-anchored β-lactamases may remain physically close to the producing cell and hence provide a more localized benefit; they also may be protected from loss but less available to detoxify the broader environment. OMVs are a route by which β-lactamase molecules can be exported from producer cells into the extracellular milieu; OMV-associated enzymes can extend the spatial range of protection and increase the opportunity for cross-protection of susceptible neighbours. The review highlights that these mechanisms create variation in the effective sharing of resistance, which has consequences for within-population dynamics.
Beyond molecular localisation, the structure and composition of bacterial populations and their environments determine whether non-producers can successfully exploit β-lactamase-mediated detoxification. In dense, well-mixed populations the bystander benefit of extracellular enzyme activity may be widespread, increasing opportunities for non-producer 'cheats' to persist. Conversely, in spatially structured populations or when producers and non-producers are segregated, the benefit of extracellular detoxification may remain local to producing lineages, reducing the fitness advantage available to cheats.
The review stresses that such population-level factors interact with mechanistic features to set the balance of private versus shared benefits. Therefore, predicting the emergence and stability of cooperator–cheat dynamics requires integrating information about enzyme localisation, secretion mechanisms, and the spatial structure of bacterial communities.
The authors argue that β-lactamase-mediated resistance should not be categorised simply as cooperative or non-cooperative. Instead, the enzyme’s sociality lies on a continuum. At one extreme, β-lactamase activity provides largely private protection to the producing cell because the enzyme acts intracellularly or remains membrane-associated. At the other extreme, enzymes exported to the extracellular environment or packaged in OMVs produce broad communal protection and function as a cooperative public good.
Recognising this continuum reframes how we interpret experimental observations and evolutionary models. It clarifies why different studies may report contrasting outcomes on the stability of cooperation and the rise of non-producing cheats: differences in mechanistic and ecological context can shift where a system sits on the private–cooperative axis.
Understanding the variation in β-lactamase sociality has direct implications for evolutionary biology and for clinical practice. From an evolutionary perspective, whether a resistance determinant acts more privately or more cooperatively affects selection pressures on producers versus non-producers and therefore the trajectory of resistance alleles in microbial populations. From a clinical perspective, the extent of extracellular detoxification can influence treatment efficacy: if β-lactamase activity is widely shared, antibiotic concentrations that would otherwise sterilise a mixed population may be insufficient, whereas predominantly private action may limit cross-protection and reduce community-level resistance.
The review highlights that models and interventions that ignore mechanistic details such as subcellular localisation, membrane anchoring, OMV-mediated export, and population structure risk mispredicting evolutionary outcomes and treatment responses. Incorporating these sources of variation can improve predictions about the spread of resistance and inform strategies to mitigate it.
This synthesis appears as a review in Essays Biochem (2026) by Rosie Randall and Ashleigh S Griffin from the Department of Biology, University of Oxford. The article underscores that β-lactamase-mediated resistance spans a continuum from private to cooperative, driven by mechanistic and ecological factors, and argues that acknowledging this variation is important for both understanding the evolution of antimicrobial resistance and anticipating clinical treatment outcomes. DOI: 10.1042/EBC20250041; PubMed ID: 42083742.